From first symptom to the right treatment - guided, compared, booked. Built on 24 years of proven German-Swiss healthcare infrastructure.

Thailand is a highly relevant launch market for digital healthcare access, patient navigation, and medical tourism enablement.
Patients often start with uncertainty and incomplete information.
Price, provider fit, and availability are difficult to compare.
Language, access, and coordination remain major barriers.
The system helps structure the user's healthcare need.
Patients do not just search - they receive and compare options.
Medical records remain under the user's control within the DEMedic environment.
DEMedic Thailand is built on an established healthcare technology platform with long-term operational experience in Germany and Switzerland. The core technology is already built and tested. The Thailand project focuses on localization, launch, partnerships, and market entry.
As of June 2026
DEMedic is positioned to become a high-value access layer between patients and healthcare providers. By supporting demand generation, provider matching, offer comparison, and booking, the platform can occupy a premium position in the healthcare journey.
With successful execution, this position can evolve into a scalable transaction and distribution layer across Thailand's healthcare market. Over a 3–4 year horizon, this may create meaningful strategic optionality for investors through cash-generating participation, partnership-driven expansion, or strategic transaction pathways including a favorable exit.
DEMedic is designed to sit where patient demand meets healthcare supply — a high-value position in the treatment journey.
As adoption grows, the platform can deepen its role in patient access, provider participation, and treatment-related transactions.
The 3–4 year objective is to build a position that may support long-term cash generation, strategic partnerships, or broader strategic transaction outcomes.
DEMedic is not only a digital health product — it is designed to become a strategic access and transaction layer within the healthcare market.
The Thailand launch is currently being prepared through a founder-led market-entry phase. The core team is already active in Bangkok and working on local rollout preparation, institutional dialogue, and partnership development.
The project is now in the formal BOI application process for the planned Thai operating company under BOI category 8.1.1 for software and digital platform activities, including related investment incentives.
In parallel, DEMedic Thailand is in an active process with DEPA Thailand regarding potential public-sector support, ecosystem access and access to relevant investor networks.
The project is currently being introduced to selected venture capital funds, angel networks and strategic investors. Qualified private investors may also participate in the current early investment opportunity, subject to individual review and availability.
Hospital groups, healthcare operators, clinic networks, medical-tourism stakeholders.
Digital transformation, healthcare innovation, AI adoption, pilot and policy dialogue.
Seed-stage and strategic market-entry partners with healthcare, AI, or Southeast Asia interest.
We welcome dialogue with strategic partners, institutional stakeholders, and aligned investors interested in the Thailand launch of DEMedic.